Skip to content

Study on clinical application of aromatherapy for patients with fibromyalgia

Study on clinical application of aromatherapy for patients with fibromyalgia - Study on clinical application of aromatherapy for patients with fibromyalgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043490
Enrollment
6
Registered
2021-03-03
Start date
2019-12-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fibromyalgia

Interventions

Instruct the patient to be treated daily with oil (excluding geranium essential oil) (3 months), and instruct the patient to treat daily with oil (including geranium essential oil) (3 months) Instruct

Sponsors

International University of Health and Welfare Shioya Hospital Anesthesiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who visit from June 1, 2019 to June 1, 2020 2. Patients who can obtain written consent from voluntary research participation 3. Patients who are 20 years old or older and younger than 80 years old when obtaining consent 4. Gender: male and female

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or may be pregnant

Design outcomes

Primary

MeasureTime frame
At the consultation, the pain clinic doctor measures the numeric rating scale, pain disability assessment scale, EuroQol, and Self-Rating Depression Scale on an outpatient basis.

Secondary

MeasureTime frame
Observation and inspection are performed for the following items. Also, we will ask for a response to the questionnaire and use the data for this study. These are activities that go beyond normal practice and are performed for research purposes. 1) Basic patient information: age, gender, medical history, height, weight, etc. 2) Blood test 3) Evaluation items of State trait Anxiety Inventery (STAI), numeric rating scale, Pain disability assessment scale, EuroQol, and Self-Rating Depression Scale measured by the attending physician before and after aromatherapy was performed. 4) Biomarkers in saliva (chromogranin A, cortisol, alpha-amylase) 5) Blood pressure and heart rate 6) Oral medication

Countries

Japan

Contacts

Public ContactRyuichiro Masubuchi

International University of Health and Welfare Shioya Hospital Pharmaceutical department

ryu.masu@iuhw.ac.jp0287-44-1155

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026